DXCM
DEXCOM INC
NASDAQ · Healthcare · Medical - Devices · US
$82.97
−2.11%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$84.55
From 52W high−10.15%
Volume4.11M
Market cap$30.94B
P/E (TTM)32.0x
P/S (TTM)6.1x
Div yield—
Key dataNov 3, 2026
Open
$84.55
From 52W high
−10.15%
Volume
4.11M
Market cap
$30.94B
ValuationView details →
P/E (Fwd)
28.1x
EV/EBITDA
19.7x
P/E (TTM)
32.0x
RSI (14)
52.3
MomentumView details →
1D Return
−2.11%
YTD Return
+26.56%
SummaryUpdated Sep 1, 2026
DexCom, Inc. (NASDAQ:DXCM) is a San Diego-based medical device company founded in 1999 that specializes in continuous glucose monitoring (CGM) systems for diabetes management. The company went public in 2005 and has grown to become a leading player in the diabetes technology market, serving approximately 2.8 million customers globally as of 2024. DexCom has evolved from a specialized medical device manufacturer to a comprehensive diabetes management platform, expanding its reach from traditional insulin-dependent patients to broader diabetes populations and even pre-diabetic individuals through its over-the-counter product offerings.
Similar companies
Latest newsMore news →
DEXCOM INC shares rose after the company reported third-quarter earnings and revenue above estimates and improved its 2026 guidance.4d agoDEXCOM INC reported its third-quarter 2026 financial results.5d agoDexCom announced that its Dexcom G7 15 Day Continuous Glucose Monitoring System will become available in Canada in November 2026 for adults aged 18 and older with diabetes.6d ago